Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Gross Profit

Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.

Aurora Cannabis Inc.TSX: ACB.TO

Gross Profit · Q4 FY2026 · quarter ended Mar 2026

Gross profit declines year over year

Q4 FY2026 gross profit of CA$18.13M fell 17.2% year over year, ahead of the -46.5% change in trailing-twelve-month gross profit. Sequentially, it rose 224.7% from the prior quarter.

Context

  • Gross profit amounted to 5.2% of revenue in FY2026, down 49.4 pp from a year earlier.
  • Gross profit increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -17.2% holds above the trailing-twelve-month pace of -46.5%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$18.13M+224.7% QoQ
Last fiscal yearMar 2026
CA$16.7M-91.1% YoY
LTMMar 2026
CA$100.28M-46.5% YoY
Gross Profit past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.2%——
1 year-91.1%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Gross Profit history

CAD · from the income statement

Latest · FY2026
16.7M CAD
Year-over-year change
-91.1%
4-year CAGR
-5.8%

Gross Profit vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so gross profit is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -46.5% is the 6th highest of 8, against a peer median of -7.5%.
  • Gross profit amounts to 31.5% of revenue for ACB.TO, versus a peer median of 50.9%.
ACB.TO Competitors
Gross Profit for ACB.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TSND.TOTerrAscend Corp.LTM Mar 2026$133.27M USD-10.0%+3.6%50.9%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$100.28M CAD-46.5%—31.5%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$75.4M CAD+9.0%+73.8%47.5%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$73.53M CAD-7.5%—23.6%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$47.19M USD+69.1%+204.4%92.2%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$37.95M USD+33.5%+26.5%74.5%
EDT.TOSpectral Medical Inc.LTM Mar 2026-CA$2.19M CAD-303.3%—79.2%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-CA$8.41M CAD-113.3%—3.1%
Peer median (excluding ACB.TO) —-7.5%+50.2%50.9%

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.